Annual CFF
$6.04 M
+$5.96 M+7118.64%
01 June 2024
Summary:
Alterity Therapeutics Limited annual cash flow from financing activities is currently $6.04 million, with the most recent change of +$5.96 million (+7118.64%) on 01 June 2024. During the last 3 years, it has fallen by -$21.34 million (-77.94%). ATHE annual CFF is now -81.18% below its all-time high of $32.10 million, reached on 30 June 2014.ATHE Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$9600.00
+$500.00+4.95%
01 June 2024
Summary:
Alterity Therapeutics Limited quarterly cash flow from financing activities is currently -$9600.00, with the most recent change of +$500.00 (+4.95%) on 01 June 2024. Over the past year, it has increased by +$500.00 (+4.95%).ATHE Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$9600.00
+$75.20 K+88.68%
01 June 2024
Summary:
Alterity Therapeutics Limited TTM cash flow from financing activities is currently -$9600.00, with the most recent change of +$75.20 thousand (+88.68%) on 01 June 2024. Over the past year, it has increased by +$75.20 thousand (+88.68%).ATHE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATHE Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +7118.6% | +5.0% | +88.7% |
| 3 y3 years | -77.9% | - | - |
| 5 y5 years | -33.6% | - | - |
ATHE Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -77.9% | +7118.6% | at high | +96.8% | at high | +98.0% |
| 5 y | 5 years | -77.9% | +7118.6% | at high | +96.8% | at high | +98.0% |
| alltime | all time | -81.2% | +5122.4% | <-9999.0% | +96.8% | <-9999.0% | +98.0% |
Alterity Therapeutics Limited Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2024 | $6.04 M(+7118.6%) | -$9600.00(-5.0%) | -$9600.00(-88.7%) |
| June 2023 | $83.70 K(-99.3%) | -$10.10 K(-86.5%) | -$84.80 K(-66.4%) |
| Dec 2022 | - | -$74.70 K(-58.0%) | -$252.40 K(-46.8%) |
| June 2022 | $11.82 M(-56.8%) | -$177.70 K(-40.2%) | -$474.80 K(+59.8%) |
| Dec 2021 | - | -$297.10 K(+1829.2%) | -$297.10 K(+1829.2%) |
| June 2021 | $27.38 M(+924.7%) | - | - |
| June 2020 | $2.67 M(-70.6%) | - | - |
| Dec 2019 | - | -$15.40 K(<-9900.0%) | -$15.40 K(<-9900.0%) |
| June 2019 | $9.10 M(<-9900.0%) | - | - |
| June 2018 | -$83.30 K(-30.8%) | - | - |
| June 2017 | -$120.30 K(<-9900.0%) | - | - |
| June 2016 | $0.00(-100.0%) | - | - |
| Dec 2015 | - | $0.00 | $0.00 |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | $5.73 M(-82.2%) | - | - |
| June 2014 | $32.10 M(+100.6%) | - | - |
| June 2013 | $16.00 M(+328.3%) | - | - |
| June 2012 | $3.74 M(-54.5%) | - | - |
| June 2011 | $8.21 M(+64.6%) | - | - |
| June 2010 | $4.99 M(+6533.2%) | - | - |
| June 2009 | $75.20 K(-99.4%) | - | - |
| June 2008 | $12.30 M(+112.2%) | - | - |
| June 2007 | $5.80 M(<-9900.0%) | - | - |
| June 2006 | -$1500.00(-100.0%) | - | - |
| June 2005 | $3.53 M(-84.3%) | - | - |
| June 2004 | $22.54 M(+983.5%) | - | - |
| June 2003 | $2.08 M(+584.3%) | - | - |
| June 2002 | $304.00 K | - | - |
FAQ
- What is Alterity Therapeutics Limited annual cash flow from financing activities?
- What is the all time high annual CFF for Alterity Therapeutics Limited?
- What is Alterity Therapeutics Limited annual CFF year-on-year change?
- What is Alterity Therapeutics Limited quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Alterity Therapeutics Limited?
- What is Alterity Therapeutics Limited quarterly CFF year-on-year change?
- What is Alterity Therapeutics Limited TTM cash flow from financing activities?
- What is the all time high TTM CFF for Alterity Therapeutics Limited?
- What is Alterity Therapeutics Limited TTM CFF year-on-year change?
What is Alterity Therapeutics Limited annual cash flow from financing activities?
The current annual CFF of ATHE is $6.04 M
What is the all time high annual CFF for Alterity Therapeutics Limited?
Alterity Therapeutics Limited all-time high annual cash flow from financing activities is $32.10 M
What is Alterity Therapeutics Limited annual CFF year-on-year change?
Over the past year, ATHE annual cash flow from financing activities has changed by +$5.96 M (+7118.64%)
What is Alterity Therapeutics Limited quarterly cash flow from financing activities?
The current quarterly CFF of ATHE is -$9600.00
What is the all time high quarterly CFF for Alterity Therapeutics Limited?
Alterity Therapeutics Limited all-time high quarterly cash flow from financing activities is $0.00
What is Alterity Therapeutics Limited quarterly CFF year-on-year change?
Over the past year, ATHE quarterly cash flow from financing activities has changed by +$500.00 (+4.95%)
What is Alterity Therapeutics Limited TTM cash flow from financing activities?
The current TTM CFF of ATHE is -$9600.00
What is the all time high TTM CFF for Alterity Therapeutics Limited?
Alterity Therapeutics Limited all-time high TTM cash flow from financing activities is $0.00
What is Alterity Therapeutics Limited TTM CFF year-on-year change?
Over the past year, ATHE TTM cash flow from financing activities has changed by +$75.20 K (+88.68%)